CERC Multidisciplinary Cardio-Endo-Renal Collaborative Supplement

MD Magazine March 2018 Supplement

This activity is jointly provided by Global Education Group and Physicians’ Education Resource®, LLC.

This activity is supported by educational grants from Amarin Pharma Inc.; AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC; Novo Nordisk Inc.; and Shire


Executive Director, Interventional Cardiovascular Programs
Brigham and Women’s Hospital Heart & Vascular Center
Professor of Medicine, Harvard Medical School
Boston, Massachusetts

Carlos M. Grilo, PhD
Professor of Psychiatry, Yale School of Medicine
Professor of Psychology, Yale University
Director, Program for Obesity Weight and Eating Research (POWER), Yale School of Medicine
New Haven, Connecticut

Silvio E. Inzucchi, MD
Professor of Medicine
Clinical Director, Section of Endocrinology
Medical Director, Yale Diabetes Center
Director, Endocrinology & Metabolism Fellowship
Director, Yale Affiliated Hospitals Program
New Haven, Connecticut

Howard S. Weintraub, MD FACC, FASPC
Clinical Professor of Medicine
Department of Medicine, Division of Cardiology
New York University School of Medicine
New York, New York

Activity Overview

This activity covers clinically relevant topics in cardiometabolic health, including cardiovascular disease prevention, dyslipidemia, diabetes, acute coronary syndrome, and obesity management. This supplement will offer health care professionals the opportunity to advance their understanding and knowledge of cardiometabolic disorders and associated comorbidities.

Learning Objectives

At the conclusion of this activity, participants should be better prepared to:
  • Examine the challenges of managing the complex cardiometabolic patient, and ways in which a team-based approach will reduce morbidity/mortality and improve patient outcomes
  • Develop effective communication strategies and collaborative care processes that will augment relationships between primary care providers and specialists, with the goal of improving health outcomes of the cardiometabolic patient
  • Explain how to engage patients in self-management of their cardiometabolic diseases by providing education about cardiovascular disease and diabetes prevention, adherence support for medication and other treatments, and tools and resources for self-management
  • Implement aggressive multifaceted and individualized strategies to attain treatment goals and improve patient outcomes

Target Audience

This educational activity is directed toward endocrinologists, cardiologists, specialty nurse practitioners, and physician assistants

Release date: February 20, 2018
Expiration date: February 20, 2019
Estimated time to complete activity: 2.0 hours
Fee: Free

Accreditation/Designation of Credit

This activity is jointly provided by Global Education Group and Physicians’ Education Resource®, LLC. AMA PRA Category 1 Credit is provided by Global Education Group.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group and Physicians’ Education Resource®, LLC. Global Education Group is accredited by the ACCME to provide continuing medical education for physicians.

Global Education Group designates this activity for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Global Contact Information

For information about the approval and accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent COI they may have as related to the content of this activity. All identified COI are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient-care recommendations.

Faculty and Staff Disclosures:

The faculty reported the following financial relationships or relationships to products or devices that they or their spouses/life partners have with commercial interests related to the content of this CME activity:

Research Funding: Amarin, Amgen, AstraZeneca, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Ironwood, Ischemix, Lilly, Medtronic, Pfizer, Roche, Sanofi Aventis, The Medicines Company

Carlos M. Grilo, PhD
Research funding: National Institutes of Health
Consultant: Shire, Sunovion
Book royalties (academic books): Guilford Press, Taylor & Francis Publishing

Silvio E. Inzucchi, MD
Research funding: National Institute of Diabetes and Digestive and Kidney Diseases
Consultant: Boehringer Ingelheim, AstraZeneca, Novo Nordisk, VTV Pharmaceuticals, Janssen, Sanofi/Lexicon, Eisai

Howard S. Weintraub, MD FACC, FASPC
Research Funding: Amarin, Sanofi
Consultant: Amarin, Sanofi
Speakers Bureau: Amgen

The following contributors have no relevant financial relationships with commercial interests to disclose.

Physicians’ Education Resource®, LLC (PER®)
Planning Staff—David Heckard; Maryjo Dixon, RPh; and Kate Bowen.

Global Education Group
Lindsay Borvansky; Andrea Funk; and Liddy Knight

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult the prescribing information for any products discussed.

The information provided in this CME/CE activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician or nurse relative to the diagnostic, treatment, or management options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of Physicians’ Education Resource®, LLC, or any of the companies that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By